Australia Synthetic Biology Market Size & Outlook, 2026-2033
Related Markets
Australia synthetic biology market highlights
- The Australia synthetic biology market generated a revenue of USD 319.6 million in 2025 and is expected to reach USD 945.7 million by 2033.
- The Australia market is expected to grow at a CAGR of 14.6% from 2026 to 2033.
- In terms of segment, pcr technology was the largest revenue generating technology in 2025.
- PCR Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
Synthetic biology market data book summary
| Market revenue in 2025 | USD 319.6 million |
| Market revenue in 2033 | USD 945.7 million |
| Growth rate | 14.6% (CAGR from 2026 to 2033) |
| Largest segment | Pcr technology |
| Fastest growing segment | PCR Technology |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR Technology, Genome Editing Technology, NGS Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global synthetic biology market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China synthetic biology market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,760.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novozymes | View profile | 5001-10000 | Bagsværd, Hovedstaden, Denmark, Europe | https://www.novozymes.com/en# |
| Synthego | View profile | 251-500 | Redwood City, California, United States, North America | http://www.synthego.com |
| Codexis Inc | View profile | 174 | 200 Penobscot Drive, Redwood, CA, United States, 94063 | https://www.codexis.com |
| DNAstar | View profile | 51-100 | Madison, Wisconsin, United States, North America | http://www.dnastar.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Australia synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 33.35% in 2025. Horizon Databook has segmented the Australia synthetic biology market based on pcr technology, genome editing technology, ngs technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2021 to 2033.
Strong support from government and nongovernment organizations is expected to drive the demand for synthetic biology in Australia. For instance, Synthetic Biology Australasia (SBA) is a nonprofit community to support growing research in synthetic biology in New Zealand, Australia, and the broader Australasian region.
It promotes collaborations within academia and between academia &industry. Moreover, it engaged in education, public outreach, and training in synthetic biology. Moreover, CSIR Synthetic Biology Future Science Platform (FSP) plays a role in the growth of synthetic biology in Australia.
Synthetic biology is expected to transform existing industries and create novel business for Australia in industrial biotechnology, health, and agriculture. Moreover, increasing funding for synthetic biology in Australia is expected to drive market growth in the country.
Reasons to subscribe to Australia synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into Australia synthetic biology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Australia synthetic biology market size, by technology, 2021-2033 (US$M)
Australia Synthetic Biology Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
